The implantable cardioverter defibrillator (ICD) represented a breakthrough in the prevention of sudden cardiac death. In addition to its use in secondary prevention, the indication of ICD therapy in primary prevention is also being intensively researched. A study published last year evaluated the relevance of ICD implantation in the acute phase of acute myocarditis and a registry study investigated the benefits of a wearable cardioverter defibrillator (WCD) for the prevention of sudden cardiac death in post-infarction patients.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Long-term study with dementia patients
Ginkgo biloba extract significantly reduces the risk of progression
- Intestinal microbiome
Complex and fragile system of microorganisms
- Cancer prevention
Poorer prognosis for men who avoid prostate cancer screening
- Diabetes mellitus
Treatment of comorbidities in older people
- Liver steatosis with metabolic dysfunction
New nomenclature for non-alcoholic fatty liver disease
- Type 2 diabetes: PAD and diabetic foot syndrome
Prevention is better than cure – don’t miss the risk foot
- Prostate cancer
High-resolution ultrasound could diagnose prostate cancer faster
- Chronic lung diseases